{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:35:05Z","timestamp":1790620505142,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Our objective was to describe day-to-day evolution and variations in patient-reported stent-associated symptoms (SAS) in the STudy to Enhance uNderstanding of sTent-associated Symptoms (STENTS), a prospective multicenter observational cohort study, using multiple instruments with conceptual overlap in various domains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a nested cohort of the STENTS study, the initial 40 participants having unilateral ureteroscopy (URS) and stent placement underwent daily assessment of self-reported measures using the Brief Pain Inventory short form, Patient-Reported Outcome Measurement Information System measures for pain severity and pain interference, the Urinary Score of the Ureteral Stent Symptom Questionnaire, and Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index. Pain intensity, pain interference, urinary symptoms, and bother were obtained preoperatively, daily until stent removal, and at postoperative day (POD) 30.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age was 44\u00a0years (IQR 29,58), and 53% were female. The size of the dominant stone was 7.5\u00a0mm (IQR 5,11), and 50% were located in the kidney. There was consistency among instruments assessing similar concepts. Pain intensity and urinary symptoms increased from baseline to POD 1 with apparent peaks in the first 2\u00a0days, remained elevated with stent in situ, and varied widely among individuals. Interference due to pain, and bother due to urinary symptoms, likewise demonstrated high individual variability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This first study investigating daily SAS allows for a more in-depth look at the lived experience after URS and the impact on quality of life. Different instruments measuring pain intensity, pain interference, and urinary symptoms produced consistent assessments of patients\u2019 experiences. The overall daily stability of pain and urinary symptoms after URS was also marked by high patient-level variation, suggesting an opportunity to identify characteristics associated with severe SAS after URS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-022-01004-9","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T09:02:48Z","timestamp":1649235768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Quality of life impact and recovery after ureteroscopy and stent insertion: insights from daily surveys in STENTS"],"prefix":"10.1186","volume":"22","author":[{"given":"Jonathan D.","family":"Harper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana C.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi A.","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory E.","family":"Tasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin B.","family":"Ziemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein R.","family":"Al-Khalidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Henry","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim M.","family":"Maalouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter B.","family":"Wessells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziya","family":"Kirkali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Charles D.","family":"Scales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"NIDDK Urinary Stone Disease Research Network (USDRN)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"1004_CR1","unstructured":"Chapter 4.3 Surgical Procedures. In: Feinstein L, Matlaga B. Urologic Diseases in America. National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Printing Office, 2018; NIH Publication No. 12-7865; 9\u201310."},{"key":"1004_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1089\/end.2013.0580","volume":"28","author":"BR Matlaga","year":"2014","unstructured":"Matlaga BR, Meckley LM, Kim M, et al. Management patterns of medicare patients undergoing treatment for upper urinary tract calculi. J Endourol. 2014;28:723\u20138.","journal-title":"J Endourol"},{"key":"1004_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.urology.2018.03.019","volume":"117","author":"HR Mittakanti","year":"2018","unstructured":"Mittakanti HR, Conti SL, Pao AC, et al. Unplanned emergency department visits and hospital admissions following ureteroscopy: do ureteral stents make a difference? Urology. 2018;117:44\u20139.","journal-title":"Urology"},{"key":"1004_CR4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.urology.2007.10.073","volume":"71","author":"DV Makarov","year":"2008","unstructured":"Makarov DV, Trock BJ, Allaf ME, et al. The effect of ureteral stent placement on post-ureteroscopy complications: a meta-analysis. Urology. 2008;71:796\u2013800.","journal-title":"Urology"},{"key":"1004_CR5","doi-asserted-by":"crossref","unstructured":"Ordonez M, Hwang EC, Borofsky M, et al. Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi. Cochrane Database Syst Rev. 2019;2:CD012703.","DOI":"10.1002\/14651858.CD012703.pub2"},{"key":"1004_CR6","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.juro.2016.05.109","volume":"196","author":"VM Pais Jr","year":"2016","unstructured":"Pais VM Jr, Smith RE, Stedina EA, et al. Does omission of ureteral stents increase risk of unplanned return visit? a systematic review and meta-analysis. J Urol. 2016;196:1458\u201366.","journal-title":"J Urol"},{"key":"1004_CR7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1089\/end.2020.0776","volume":"35","author":"CD Scales Jr","year":"2021","unstructured":"Scales CD Jr, Lai HH, Desai AC, et al. Study to Enhance Understanding of Stent-Associated Symptoms: rationale and study design. J Endourol. 2021;35:761\u20138.","journal-title":"J Endourol"},{"key":"1004_CR8","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23:129\u201338.","journal-title":"Ann Acad Med Singap"},{"key":"1004_CR9","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","volume":"45","author":"D Cella","year":"2007","unstructured":"Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007;45:S3-11.","journal-title":"Med Care"},{"key":"1004_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/01.ju.0000049198.53424.1d","volume":"169","author":"HB Joshi","year":"2003","unstructured":"Joshi HB, Newns N, Stainthorpe A, et al. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol. 2003;169:1060\u20134.","journal-title":"J Urol"},{"key":"1004_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/JU.0000000000000465","volume":"203","author":"D Cella","year":"2020","unstructured":"Cella D, Smith AR, Griffith JW, et al. A new brief clinical assessment of lower urinary tract symptoms for women and men: LURN SI-10. J Urol. 2020;203:164\u201370.","journal-title":"J Urol"},{"key":"1004_CR12","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1016\/j.juro.2009.02.019","volume":"181","author":"JE Lingeman","year":"2009","unstructured":"Lingeman JE, Preminger GM, Goldfischer ER, et al. Comfort Study Team: assessing the impact of ureteral stent design on patient comfort. J Urol. 2009;181:2581\u20137.","journal-title":"J Urol"},{"key":"1004_CR13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1590\/S1677-5538.IBJU.2015.0275","volume":"42","author":"Z Gul","year":"2016","unstructured":"Gul Z, Alazem K, Li I, et al. Predicting procedural pain after ureteroscopy: does hydrodistention play a role? Int Braz J Urol. 2016;42:734\u20139.","journal-title":"Int Braz J Urol"},{"key":"1004_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1046\/j.1464-410x.1999.00154.x","volume":"84","author":"J Irani","year":"1999","unstructured":"Irani J, Siquier J, Pires C, et al. Symptom characteristics and the development of tolerance with time in patients with indwelling double-pigtail ureteric stents. BJU Int. 1999;84:276\u20139.","journal-title":"BJU Int"},{"key":"1004_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.urology.2016.07.035","volume":"100","author":"FC Lee","year":"2017","unstructured":"Lee FC, Holt SK, Hsi RS, et al. Preoperative belladonna and opium suppository for ureteral stent pain: a randomized, double-blinded, placebo-controlled study. Urology. 2017;100:27\u201332.","journal-title":"Urology"},{"key":"1004_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.juro.2009.11.035","volume":"183","author":"AE Krambeck","year":"2010","unstructured":"Krambeck AE, Walsh RS, Denstedt JD, et al. A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J Urol. 2010;183:1037\u201342.","journal-title":"J Urol"},{"key":"1004_CR17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/JU.0000000000001098","volume":"204","author":"O Wiseman","year":"2020","unstructured":"Wiseman O, Ventimiglia E, Doizi S, et al. Effects of silicone hydrocoated double loop ureteral stent on symptoms and quality of life in patients undergoing flexible ureteroscopy for kidney stone: a randomized multicentre clinical study. J Urol. 2020;204:769\u201377.","journal-title":"J Urol"},{"key":"1004_CR18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.juro.2017.05.080","volume":"198","author":"MS Borofsky","year":"2017","unstructured":"Borofsky MS, Lane GI, Neises SM, et al. Patient-Reported Outcomes Measurement System (PROMIS((R))) for patients with urolithiasis: initial report. J Urol. 2017;198:1091\u20137.","journal-title":"J Urol"},{"key":"1004_CR19","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1590\/s1677-5538.ibju.2016.0649","volume":"43","author":"N Patel","year":"2017","unstructured":"Patel N, Brown RD, Sarkissian C, et al. Quality of life and urolithiasis: the patient-reported outcomes measurement information system (PROMIS). Int Braz J Urol. 2017;43:880\u20136.","journal-title":"Int Braz J Urol"},{"key":"1004_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.juro.2018.04.075","volume":"200","author":"JL Portis","year":"2018","unstructured":"Portis JL, Neises SM, Portis AJ. Pain is independent of stone burden and predicts surgical intervention in patients with ureteral stones. J Urol. 2018;200:597\u2013603.","journal-title":"J Urol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-022-01004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-022-01004-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-022-01004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T09:04:16Z","timestamp":1649235856000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-022-01004-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1004"],"URL":"https:\/\/doi.org\/10.1186\/s12894-022-01004-9","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review boards of each clinical center (University of Washington School of Medicine, University of Texas Southwestern Medical Center, Washington University School of Medicine, Children\u2019s Hospital of Philadelphia, and University of Pennsylvania) reviewed and approved the study. All procedures involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants age 18 or above included in the study. Parents provided informed consent for all minor participants (age\u2009<\u200918\u00a0years, per the Institutional Review Boards governing this study), along with the assent of each adolescent participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Antonelli has relationships with the following entities: Boston Scientific Corp, Cook Medical (Advisory Board). Dr. Tasian has relationships with the following entities: Dicerna (advisory board, scientific study), Alnylam (advisory board), Novome (advisory board), and Allena Pharmaceuticals (consultant). No other authors reported disclosures relevant to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}